Indomethacin
Product Images NDC 10544-935

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Indomethacin (NDC 10544-935). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container Label (Label Indomethacin Er Caps 75mg Bpi(10544 935 14) Camberl(31722 565 60) Rev1)

Label for Indomethacin Extended-Release Capsules, USP 75 mg, containing 14 capsules. The label indicates prescription use only, storage instructions at controlled room temperature, and child safety warnings. The manufacturer is Blenheim Pharmacal, Inc., located in New York. The label includes the NDC 10544-935-14 and other lot and expiration date placeholders.*

FDA Label Image

Structure.jpg (Structure)

Chemical structure of indomethacin, showing aromatic rings, a chlorine substituent, a methoxy group, and functional groups including a carboxylic acid and methyl groups, consistent with the active pharmaceutical ingredient indomethacin by Blenheim Pharmacal, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.